logo
Select company
Select metric
$ 0Net Income (Loss) from Discontinued Operations
VS
Market
3
Sector
3
Industry
1
History
-
$ 10.05Close
$ 3.7 - $ 11.11 52-Week Range
Ticker Information

Ticker

GLUE

Company Name

MONTE ROSA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MONTE ROSA THERAPEUTICS INC - Net Income (Loss) from Discontinued Operations Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GLUE - Net Inc. disc. Op. Historical data
DateNet Income (Loss) from Discontinued Operations
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MONTE ROSA THERAPEUTICS INC's latest trailing twelve months (TTM) Net Inc. disc. Op. stands at $ 0.
  • Over the past 5 years, MONTE ROSA THERAPEUTICS INC's average Net Inc. disc. Op. has been $ 0.
  • The median Net Inc. disc. Op. for MONTE ROSA THERAPEUTICS INC during this period was $ 0
  • MONTE ROSA THERAPEUTICS INC reached its highest Net Inc. disc. Op. over the past 5 years at $ 0.
  • The lowest Net Inc. disc. Op. recorded by MONTE ROSA THERAPEUTICS INC in the same timeframe $ 0

MONTE ROSA THERAPEUTICS INC's Net Inc. disc. Op. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net Inc. disc. Op. Benchmarks
CompanyNet Inc. disc. Op.
VNDA : VANDA PHARMACEUTICALS INC $ 0HRTX : HERON THERAPEUTICS INC $ 0ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ 0CTMX : CYTOMX THERAPEUTICS INC $ 0RGNX : REGENXBIO INC $ 0MGNX : MACROGENICS INC $ 0TRDA : ENTRADA THERAPEUTICS INC $ 0PBYI : PUMA BIOTECHNOLOGY INC $ 0CDXS : CODEXIS INC $ 0SCPH : SCPHARMACEUTICALS INC $ 0

Definition of Net Income (Loss) from Discontinued Operations

[Income Statement] Net Income (loss) from Discontinued Operations shows the after-tax gain or loss on the sale of a business segment as well as the after tax effect of the discontinued segment.

GLUE - Net Income (Loss) from Discontinued Operations, Last 5 years

$ 0

Minimum

Dec 31, 2020

$ 0

Maximum

Dec 31, 2020

$ 0

Average

$ 0

Median

Net Inc. disc. Op. Benchmark Analysis

The chart above depicts the distribution of Net Inc. disc. Op. for companies in the Total Stock Market. The average Net Inc. disc. Op. of the companies is $ -255.06K with a standard deviation of $ 109.16M.
The following table provides additional summary stats:
Net Inc. disc. Op. in the Market:
filtered constituents4.27K
min$ -2.73B
max$ 4.03B
average$ -255.06K
median$ 0
std$ 109.16M